Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
1. |
ECCT/26/03/02 | E-MASTER STUDY: PHASE 1 Diagnosis of postpartum haemorrhage at caesarean section: a multi-country diagnostic and prognostic accuracy study (E-MASTER: PHASE 1) |
Principal Investigator(s) 1. Zahida Qureshi 2. Alfred Osoti 3. George Gwako Site(s) in Kenya 1. St Marys Mission Hospital-Langata (Nairobi City county) 2. Mbagathi County Referral Hospital (Nairobi City county) |
04-06-2026 |
View |
2. |
ECCT/26/03/01 | C1091009 Study A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants |
Principal Investigator(s) 1. Lucas Otieno Tina Site(s) in Kenya 1. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county) 2. KEMRI Butere Clinical Research Centre (Kakamega county) 3. Kenya Medical Research Institute Walter Reed Project (Kericho county) 4. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county) |
26-08-2026 |
View |
3. |
ECCT/26/02/07 | IMPAACT 2024 Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV |
Principal Investigator(s) 1. LUCY Chepkurui Koech Site(s) in Kenya Kenya Medical Research Institute/Walter Reed Project(KEMRI/WRP) |
27-08-2026 |
View |
4. |
ECCT/26/02/02 | REVIVE Study - JOOTRH A randomised, double blinded, placebo-controlled, multicentre trial of azithromycin prophylaxis for advanced HIV disease |
Principal Investigator(s) 1. Loice Achieng Ombajo Site(s) in Kenya 1. Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) (Kisumu county) |
22-08-2026 |
View |
5. |
ECCT/26/02/03 | REVIVE Study - KNH A randomised, double blinded, placebo-controlled, multicentre trial of azithromycin prophylaxis for advanced HIV disease |
Principal Investigator(s) 1. Loice Achieng Ombajo Site(s) in Kenya 1. Kenyatta National Hospital (KNH) (Nairobi City county) |
28-09-2026 |
View |
6. |
ECCT/26/02/04 | RSV IMPACT TRIAL A Phase-IIIb individually randomized, placebo-controlled trial on safety of RSVA/B-preF vaccine in pregnant women and efficacy against severe RSV-associated lower respiratory tract infection (LRTI) in infants. |
Principal Investigator(s) 1. Joyce Uchi Nyiro 2. Makobu Kimani Site(s) in Kenya 1. Kilifi, KEMRI-Centre for Geographic Medicine Research Coast (CGMRC) (Kilifi county) |
28-05-2026 |
View |
7. |
ECCT/25/12/04 | Floral Study An open-label, multi-centre, rollover study to characterise long-term safety and efficacy of etavopivat in adults, adolescents and children who have sickle cell disease or thalassaemia and have completed a treatment period in an etavopivat study |
Principal Investigator(s) 1. Walter Otieno Site(s) in Kenya 1. Kombewa Clinical Research Center (Kisumu county) 2. KEMRI Kondele Children\'s Hospital (Kisumu county) 3. Center for Research in Therapeutic Sciences (CREATES) (Kisumu county) 4. KEMRI Siaya Clinical Research Annex (Siaya county) 5. KEMRI WALTER REED KERICHO (Kericho county) 6. Getrude\'s Children\'s Hospital (Nairobi City county) |
13-04-2026 |
View |
8. |
ECCT/25/11/05 | MK-8527-011 Study A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis |
Principal Investigator(s) 1. Dr. Joshua Kimani Site(s) in Kenya 1. Nyanza Reproductive Health Society (NRHS), UNIM Research and Training Centre (URTC) (Kisumu county) 2. Partners for Health and Development in Africa – Sex workers Outreach Program (PHDA – SWOP) Clinic- Nairobi, Kenya (Nairobi City county) 3. Kenya Impact Research and Development Organization (K-IRDO) (Kisumu county) |
05-03-2026 |
View |
9. |
ECCT/26/04/02 | IGHID 12430/DELIVER-02 IGHID12430/DELIVER-02 - A PHASE 1, OPEN LABEL,STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF MGD014 AND MGD020 WITH A LATENCY REVERSAL AGENT VERSUS TEMPORARY TREATMENT INTERRUPTION IN PERSONS WITH HIV-1 ON ANTIRETROVIRAL THERAPY |
Principal Investigator(s) 1. Charity Wambui Kanyoro Site(s) in Kenya 1. Moi University Clinical Research Centre(MUCRC), Eldoret, Kenya (Uasin Gishu county) 2. Kericho Clinical Research Center (Kericho CRC), Kericho, (Kericho county) |
25-06-2026 |
View |
10. |
ECCT/25/12/05 | Floral Study An open-label, multi-centre, rollover study to characterise long-term safety and efficacy of etavopivat in adults, adolescents and children who have sickle cell disease or thalassaemia and have completed a treatment period in an etavopivat study |
Principal Investigator(s) 1. Janet Oyieko Site(s) in Kenya 1. Kombewa Clinical Research Center (Kisumu county) 2. Center for Research in Therapeutic Sciences (CREATES) (Kisumu county) 3. Gertrude\'s Children\'s Hospital (Nairobi City county) 4. KEMRI Siaya Clinical Research Annex (Siaya county) 5. KEMRI WALTER REED KERICHO (Kericho county) 6. KEMRI Kondele Children\'s Hospital (Kisumu county) |
13-04-2026 |
View |